Is Peritine, a diet drug legally listed in Taiwan Province Province and the United States, at risk of spreading cancer? It is reported that the US Food and Drug Administration (FDA) warned that taking this prescription drug has a high cancer risk. The manufacturer stressed that after actually browsing the FDA official website, it was found that the first paragraph of the FDA statement alleged that "perrietine can not be determined to cause cancer, and the cause of cancer is uncertain, which needs further exploration. 」
Follow-up of legally marketed diet pills after listing.
According to the management information system of drug certificate business of the US Food and Drug Administration in Taiwan Province Province, the indication of Peiliting is to lose weight by suppressing appetite, which belongs to prescription drugs. The list of generic drugs includes warnings such as heart valve disease, decreased heart rate, pulmonary hypertension and erectile dysfunction.
Chuangyi Biotechnology, which is responsible for marketing perpetidine, said that the FDA's drug safety statement mentioned the original pharmaceutical factory that developed perpetidine. In order to obtain FDA certification, a five-year clinical trial is needed with12,000 participants. The main purpose of this experiment is to study drugs that increase the incidence of cardiovascular events, not to analyze the incidence of cancer. If the intake is used according to the doctor's advice, taking drugs has nothing to do with increasing the incidence of tumors, the New England Journal of Medicine reported, taking Perpethidine.
According to the doctor's advice, the intake has nothing to do with the occurrence of tumors.
Chuangyi Biotechnology pointed out that according to the animal experiments published in the imitation list, the original pharmaceutical factory, at the request of the FDA, administered drugs to male rats and female rats at doses 0/7 times and 87 times higher than the human dose/kloc-,which had already exceeded the maximum tolerated dose (MTD) of animals. If taken according to the doctor's advice, taking drugs has nothing to do with increasing the incidence of cancer.
Patients should not stop taking drugs at will, and consult a doctor if in doubt.
It is reported that Peletin has been licensed in six countries and listed in four countries, including the United States, Israel, Taiwan Province Province of China and South Korea. Chuangyi Bio emphasized that during the seven years since Peletine was listed in the United States, pharmaceutical companies have been continuously monitoring and collecting safety information. At present, no carcinogenic doubts have been found. At present, we will continue to closely monitor drug safety with Taiwan Province Food and Drug Administration, and also appeal to patients not to stop taking drugs without consulting the attending physician, so as not to affect their treatment rights. If people have any questions about product consultation, please contact Chuangyi Biotechnology Service Hotline.
Join us and pay attention to your health every day! Line @ ID: @ Subscribe to Healthy Aloha Audio-visual Channel to read health knowledge more easily: /beauty/article/44988 Keywords: diet pills, cancer, drug safety, weight loss, appetite suppression, animal testing.